[Comment] Effect of neoadjuvant chemoradiotherapy with or without PD-1 antibody sintilimab in pMMR locally advanced rectal cancer: a randomized clinical trial
Neoadjuvant chemoradiotherapy (NACRT) was the standard treatment for patients with locally advanced rectal cancer (LARC) with proficient mismatch repair (pMMR) proteins. In this randomized phase 2 trial (ClinicalTrial. gov:NCT04304209), 134 pMMR LARC patients were randomly (1∶ 1) assigned to receive...
Saved in:
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | zho |
| Published: |
Editorial Office of Journal of Colorectal & Anal Surgery
2025-02-01
|
| Series: | 结直肠肛门外科 |
| Subjects: | |
| Online Access: | https://jzcgmwk.cbpt.cnki.net/WKD/WebPublication/paperDigest.aspx?paperID=e3116b37-ae1c-475b-b227-3a79824dcdd3 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|